Passive immunization with influenza haemagglutinin specific monoclonal antibodies
Identifieur interne : 000167 ( Main/Exploration ); précédent : 000166; suivant : 000168Passive immunization with influenza haemagglutinin specific monoclonal antibodies
Auteurs : Rajeev Rudraraju ; Kanta SubbaraoSource :
- Human Vaccines & Immunotherapeutics [ 2164-5515 ] ; 2018.
Abstract
The isolation of broadly neutralising antibodies against the influenza haemagglutinin has spurred investigation into their clinical potential, and has led to advances in influenza virus biology and universal influenza vaccine development. Studies in animal models have been invaluable for demonstrating the prophylactic and therapeutic efficacy of broadly neutralising antibodies, for comparisons with antiviral drugs used as the standard of care, and for defining their mechanism of action and potential role in providing protection from airborne infection.
Url:
DOI: 10.1080/21645515.2018.1489947
PubMed: 29985756
PubMed Central: 6314409
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000475
- to stream Pmc, to step Curation: 000475
- to stream Pmc, to step Checkpoint: 000118
- to stream Ncbi, to step Merge: 000E95
- to stream Ncbi, to step Curation: 000E95
- to stream Ncbi, to step Checkpoint: 000E95
- to stream Main, to step Merge: 000167
- to stream Main, to step Curation: 000167
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Passive immunization with influenza haemagglutinin specific monoclonal antibodies</title><author><name sortKey="Rudraraju, Rajeev" sort="Rudraraju, Rajeev" uniqKey="Rudraraju R" first="Rajeev" last="Rudraraju">Rajeev Rudraraju</name><affiliation><nlm:aff id="AFF0001"></nlm:aff></affiliation></author><author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name><affiliation><nlm:aff id="AFF0001"></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">29985756</idno><idno type="pmc">6314409</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314409</idno><idno type="RBID">PMC:6314409</idno><idno type="doi">10.1080/21645515.2018.1489947</idno><date when="2018">2018</date><idno type="wicri:Area/Pmc/Corpus">000475</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000475</idno><idno type="wicri:Area/Pmc/Curation">000475</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000475</idno><idno type="wicri:Area/Pmc/Checkpoint">000118</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000118</idno><idno type="wicri:Area/Ncbi/Merge">000E95</idno><idno type="wicri:Area/Ncbi/Curation">000E95</idno><idno type="wicri:Area/Ncbi/Checkpoint">000E95</idno><idno type="wicri:doubleKey">2164-5515:2018:Rudraraju R:passive:immunization:with</idno><idno type="wicri:Area/Main/Merge">000167</idno><idno type="wicri:Area/Main/Curation">000167</idno><idno type="wicri:Area/Main/Exploration">000167</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Passive immunization with influenza haemagglutinin specific monoclonal antibodies</title><author><name sortKey="Rudraraju, Rajeev" sort="Rudraraju, Rajeev" uniqKey="Rudraraju R" first="Rajeev" last="Rudraraju">Rajeev Rudraraju</name><affiliation><nlm:aff id="AFF0001"></nlm:aff></affiliation></author><author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name><affiliation><nlm:aff id="AFF0001"></nlm:aff></affiliation></author></analytic><series><title level="j">Human Vaccines & Immunotherapeutics</title><idno type="ISSN">2164-5515</idno><idno type="eISSN">2164-554X</idno><imprint><date when="2018">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>ABSTRACT</title><p>The isolation of broadly neutralising antibodies against the influenza haemagglutinin has spurred investigation into their clinical potential, and has led to advances in influenza virus biology and universal influenza vaccine development. Studies in animal models have been invaluable for demonstrating the prophylactic and therapeutic efficacy of broadly neutralising antibodies, for comparisons with antiviral drugs used as the standard of care, and for defining their mechanism of action and potential role in providing protection from airborne infection.</p></div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Rudraraju, Rajeev" sort="Rudraraju, Rajeev" uniqKey="Rudraraju R" first="Rajeev" last="Rudraraju">Rajeev Rudraraju</name><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000167 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000167 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:6314409
|texte= Passive immunization with influenza haemagglutinin specific monoclonal antibodies
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:29985756" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |